Author:
Rob Fredericksen,Emma Fitzsimmons,Maksim Sigal,Sarah Dougherty,John Pearce,Minh Powell,John Nguyen,Stephanie Ruderman,Bridget Whitney,Lydia Drumright,Jimmy Ma,Robin Nance,Sarah Mixson,Joseph Delaney,Kenneth Mayer,Amanda Willig,Heidi Crane,Andrew Hahn
Reference34 articles.
1. Alon L, Bruce D, Blocker O, Bouris AM, Reirden DH, Schneider JA (2021). Perceptions of quality and safety in cannabis acquisition amongst young gay and bisexual men living with HIV/AIDS who use cannabis: Impact of legalization and dispensaries. International Journal of Drug Policy 88:103035.
2. Azcarate PM, Zhang AJ, Keyhani S, Steigerwald S, Ishida JH, Cohen BE (2020). Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population. Journal of General Internal Medicine 35(7):1979-1986.
3. Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA (2014). Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. Journal of Behavioral Medicine 37(1):1-10.
4. Bridgeman MB, Abazia DT (2017). Medicinal cannabis: history, pharmacology, and implications for the acute care setting. Pharmacy and Therapeutics 42(3):180.
5. Center for Behavioral Health Statistics and Quality (2016). Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51).